UPDATE – June 3, 2020: The Class Action against Johnson & Johnson has been discontinued and will not be proceeding. The discontinuance will be effective on August 28, 2020. Please find copies of the legal notices below for more detailed information and to understand how the discontinuance impacts your legal rights.
UPDATE – March 30, 2020: The Canada-wide settlement to resolve litigation against American Medical Systems Canada Inc., American Medical Systems Inc., and Endo Pharmaceuticals (“AMS”) was approved on October 4, 2019. If you were implanted with an AMS women’s pelvic mesh device(s) for treatment of Stress Urinary Incontinence (SUI) and/or for treatment of Pelvic Organ Prolapse (POP), you may be entitled to compensation. All claims must be submitted by July 27, 2020. For more information, please visit the settlement website at amsmeshclassactions.ca or contact Jon Sloan at 1-866-881-2292 ext. 299 or [email protected]. You can also find copies of the Notices below.
Update – July 11, 2019: A proposed settlement has been reached in the AMS class actions and a hearing to determine if the settlement will be approved will take place on October 4, 2019. For more details, please see the below notices or contact Jon Sloan at 1-866-881-2292 ext. 299 or [email protected].
Update – May 28, 2015: AMS class action certified. For more details, please see below for the notices:
Update – June 5, 2012: J&J Tells Judge It Will Stop Sales of Vaginal Implants
Update – April 18, 2012: Canadian Class Action Commenced against Johnson & Johnson